Cargando…
Developing tumor-specific PRO-CTCAE item sets: analysis of a cross-sectional survey in three German outpatient cancer centers
BACKGROUND: To include the patient perspective in the assessment of adverse events in oncology, a patient-reported outcomes (PRO) version of the Common Terminology Criteria for Adverse Events (CTCAE) was developed by the US National Cancer Institute, the so called PRO-CTCAE. The objective of this st...
Autores principales: | Günther, Maximilian, Hentschel, Leopold, Schuler, Markus, Müller, Theresa, Schütte, Katharina, Ko, Yon-Dschun, Schmidt-Wolf, Ingo, Jaehde, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320985/ https://www.ncbi.nlm.nih.gov/pubmed/37407982 http://dx.doi.org/10.1186/s12885-023-11115-7 |
Ejemplares similares
-
Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE(®) to Provide Two Distinct and Complementary Perspectives
por: Minasian, Lori M, et al.
Publicado: (2022) -
Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approach
por: Schmulenson, Eduard, et al.
Publicado: (2020) -
Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study
por: Krolop, Linda, et al.
Publicado: (2013) -
Predicting unplanned hospital readmission in palliative outpatients (PRePP) – study protocol of a longitudinal, prospective study to identify informal caregiver-related and structural predictors
por: Hentschel, Leopold, et al.
Publicado: (2022) -
A toolbox of different approaches to analyze and present PRO-CTCAE data in oncology studies
por: Regnault, Antoine, et al.
Publicado: (2023)